Inhibikase Therapeutics News

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Werner Milton H.

Apr 3 16:51 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lees-Rolfe Garth

Apr 2 17:17 ET

Inhibikase Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lees-Rolfe Garth

Apr 2 17:17 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERMAN DENNIS N

Jul 5, 2023 21:18 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dion Gisele

Jul 5, 2023 21:16 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GRINT PAUL C

Jul 5, 2023 21:12 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Freeman Roy Lester

Jul 5, 2023 21:11 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Werner Milton H.

Mar 3, 2023 17:00 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer FRATTAROLI JOSEPH

Mar 3, 2023 17:00 ET

Inhibikase Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-FiveT Investment Management Ltd(4.78%),FiveT Capital AG(4.78%)

Feb 24, 2023 12:27 ET

Inhibikase Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Milton H. Werner(19.68%)

Feb 15, 2023 19:45 ET

Inhibikase Therapeutics | D: Filing D

Feb 7, 2023 16:48 ET

Inhibikase Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-FiveT Investment Management Ltd(4.12%),FiveT Capital AG(4.12%)

Jan 31, 2023 11:59 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Sep 6, 2022 17:08 ET

Inhibikase Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Dion Gisele

Sep 6, 2022 17:06 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 16, 2022 16:25 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jun 28, 2022 21:00 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jun 28, 2022 21:00 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jun 28, 2022 21:00 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jun 28, 2022 21:00 ET